Renalytix

0 followers

Renalytix (LSE: RENX) (NASDAQ: RNLX) is the founder and global leader in the new field of bioprognosis™ for kidney health.

Industries

Employees

51-200

Links


Org chart

Collapse
Michael J. Donovan
Chief Medical Officer
Elise Wilfinger
Chief Strategy & Marketing Officer
Christopher Scott
Chief Operating Officer
Joel Jung
Interim Chief Financial Officer

Board & advisors

Christopher Mills
Non-Executive Director
Erik Lium
Non-Executive Director
Chirag R. Parikh
Non-Executive Director
Daniel J. Levangie
Non-Executive Director
Timothy J. Scannell
Non-Executive Directors